Last update :
19/01/2021
Anti-inflammatory   Hydroxychloroquine sulfate  
Oral solution
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Incompatibilities References Pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Hydroxychloroquine sulfate     
Container Origine Excipient Temperature Storage Length of time References
Glass Powder 5000 mg
® = ?
SyrSpend SF PH4® 6500 mg
Water for injection >> 100 mL
2-8°C Protect from light
60 Day
4492
Plastic bottle Tablets 750 mg
? (Mylan Company)
Oral Mix® >> 30 ml
19-23°C Protect from light
112 Day
3993
Level of evidence D

Plastic bottle Tablets 750 mg
? (Mylan Company)
Oral Mix SF® >> 30 ml
19-23°C Protect from light
112 Day
3993
Level of evidence D

Plastic bottle Tablets 750 mg
? (Mylan Company)
Oral Mix® >> 30 ml
4°C Protect from light
112 Day
3993
Level of evidence D

Plastic bottle Tablets 750 mg
? (Mylan Company)
Oral Mix SF® >> 30 ml
4°C Protect from light
112 Day
3993
Level of evidence D

Syringe Tablets 37.5 mg
? (Mylan Company)
Oral Mix® >> 1.5 ml
19-23°C Protect from light
112 Day
3993
Level of evidence D

Syringe Tablets 37.5 mg
? (Mylan Company)
Oral Mix SF® >> 1.5 ml
19-23°C Protect from light
112 Day
3993
Level of evidence D

Syringe Tablets 37.5 mg
? (Mylan Company)
Oral Mix® >> 1.5 ml
4°C Protect from light
112 Day
3993
Level of evidence D

Syringe Tablets 37.5 mg
? (Mylan Company)
Oral Mix SF® >> 1.5 ml
4°C Protect from light
112 Day
3993
Level of evidence D


  Mentions Légales